Sanofi Can't Ditch Ex-Worker's FCA Claims Over Cancer Drug

Law360, Los Angeles (January 10, 2017, 7:01 PM EST) -- Sanofi on Monday lost a bid to dodge False Claims Act allegations that it unlawfully marketed off-label uses of a cancer drug when a Pennsylvania federal judge said there was a genuine dispute over whether the marketing was false or misleading.  

The long-running suit was filed by Yoash Gohil, who worked as an oncology sales specialist for Aventis Pharmaceuticals Inc. and its predecessors from 1982 until 2002. He alleged that the company, which changed its name to Sanofi after a merger, spent many years unlawfully marketing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.